Neuroblastoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neuroblastoma stocks.

Neuroblastoma Stocks Recent News

Date Stock Title
May 7 YMAB Y-mAbs Therapeutics Reports Q1 2024 Results: Aligns with EPS Projections, Misses Revenue Estimates
May 7 YMAB Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates
May 7 YMAB Y-mAbs Therapeutics GAAP EPS of -$0.15 in-line, revenue of $19.93M misses by $2.29M
May 7 YMAB Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
May 7 UTHR Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
May 7 UTHR Best Value Stocks to Buy for May 7th
May 7 UTHR Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
May 7 UTHR Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)
May 6 YMAB Y-mAbs Therapeutics Q1 2024 Earnings Preview
May 6 UTHR United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why
May 6 UTHR United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?
May 3 UTHR 30 Most Profitable Companies with Highest Margins in the World
May 2 UTHR United Therapeutics (UTHR) Q1 Earnings Top, Tyvaso Drives Sales
May 2 UTHR United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
May 2 UTHR United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ...
May 2 UTHR Q1 2024 United Therapeutics Corp Earnings Call
May 1 UTHR Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity
May 1 UTHR United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript
May 1 UTHR Compared to Estimates, United Therapeutics (UTHR) Q1 Earnings: A Look at Key Metrics
May 1 KZIA KAZIA REPORTS SUCCESSFUL STAGE 1 COMPLETION OF THE EVT801 PHASE 1 CLINICAL TRIAL IN ADVANCED CANCER PATIENTS
Neuroblastoma

Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands, but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin.Occasionally, neuroblastoma may be due to a mutation inherited from a person's parents. Environmental factors have not been found to be involved. Diagnosis is based on a tissue biopsy. Occasionally it may be found in a baby by ultrasound during pregnancy. At diagnosis, the cancer has usually already spread. The cancer is divided into low-, intermediate-, and high-risk groups based on a child's age, cancer stage, and what the cancer looks like.Treatment and outcomes depends on the risk group a person is in. Treatments may include observation, surgery, radiation, chemotherapy, or stem cell transplantation. Low-risk disease in babies typically has a good outcome with surgery or simply observation. In high-risk disease, chances of long-term survival, however, are less than 40% despite aggressive treatment.Neuroblastoma is the most common cancer in babies and the third-most common cancer in children after leukemia and brain cancer. About one in every 7,000 children is affected at some time. About 90% of cases occur in children less than 5 years old and it is rare in adults. Of cancer deaths in children, about 15% are due to neuroblastoma. The disease was first described in the 1800s.

Browse All Tags